文献
J-GLOBAL ID:201802279491226350
整理番号:18A0053257
転移性大腸癌患者に対する第一選択治療としてのベバシズマブ+FOLFIRIおよびベバシズマブ+mFOLFOX6の無作為化第III相試験(WJOG4407G)
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)
著者 (48件):
YAMAZAKI K.
(Shizuoka Cancer Center, Shizuoka)
,
NAGASE M.
(Jichi Medical Univ., Shimotsuke)
,
TAMAGAWA H.
(Osaka General Medical Center, Osaka)
,
UEDA S.
(Kinki Univ. Fac. of Medicine, Higashiosaka)
,
TAMURA T.
(Nara Hospital Kinki Univ. Fac. of Medicine, Ikoma)
,
MURATA K.
(Suita Municipal Hospital, Suita)
,
EGUCHI NAKAJIMA T.
(St Marianna Univ. School of Medicine, Kawasaki)
,
BABA E.
(Kyushu Univ. Fac. of Medical Sci., Fukuoka)
,
TSUDA M.
(Hyogo Cancer Center, Akashi)
,
MORIWAKI T.
(Univ. Tsukuba, Tsukuba)
,
ESAKI T.
(National Hospital Organization Kyushu Cancer Center, Fukuoka)
,
TSUJI Y.
(Tonan Hospital, Sapporo)
,
MURO K.
(Aichi Cancer Center Hospital, Nagoya)
,
TAIRA K.
(Osaka City General Hospital, Osaka)
,
DENDA T.
(Chiba Cancer Center, Chiba)
,
FUNAI S.
(Sakai Hospital Kinki Univ. Fac. of Medicine, Sakai)
,
SHINOZAKI K.
(Hiroshima Prefectural Hospital, Hiroshima)
,
YAMASHITA H.
(Okayama Medical Center, Okayama)
,
SUGIMOTO N.
(Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka)
,
OKUNO T.
(Kobe Univ. Graduate School of Medicine, Kobe)
,
NISHINA T.
(National Hospital Organization Shikoku Cancer Center, Matuyama)
,
UMEKI M.
(Hyogo Prefectural Awaji Medical Center, Sumoto)
,
KURIMOTO T.
(Nagoya Kyoritsu Hospital, Nagoya)
,
TAKAYAMA T.
(Tokushima Univ. Graduate School, Tokushima)
,
TSUJI A.
(Kochi Health Sci. Center, Kochi)
,
YOSHIDA M.
(Osaka Medical Coll. Hospital, Takatsuki)
,
HOSOKAWA A.
(Univ. Toyama, Toyama)
,
SHIBATA Y.
(Miyazaki Prefectural Miyazaki Hospital, Miyazaki)
,
SUYAMA K.
(Toranomon Hospital, Tokyo)
,
OKABE M.
(Kurashiki Central Hospital, Kurashiki)
,
SUZUKI K.
(Kushiro City General Hospital, Kushiro)
,
SEKI N.
(Teikyo Univ. School of Medicine, Tokyo)
,
KAWAKAMI K.
(Muroran City General Hospital, Muroran)
,
SATO M.
(Ryuugasaki Saiseikai Hospital, Ryugasaki)
,
FUJIKAWA K.
(Hokkaido Cancer Center, Sapporo)
,
HIRASHIMA T.
(Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino)
,
SHIMURA T.
(Nagoya City Univ. Graduate School of Medical Sci., Nagoya)
,
TAKU K.
(Shizuoka General Hospital, Shizuoka)
,
OTSUJI T.
(Dongo Hospital, Yamatotakada)
,
TAMURA F.
(Kumamoto Regional Medical Center, Kumamoto)
,
SHINOZAKI E.
(JFCR, Tokyo)
,
NAKASHIMA K.
(Univ. Miyazaki, Miyazaki)
,
HARA H.
(Saitama Cancer Center, Saitama)
,
TSUSHIMA T.
(Shizuoka Cancer Center, Shizuoka)
,
ANDO M.
(Nagoya Univ. Hospital, Nagoya)
,
MORITA S.
(Kyoto Univ. Graduate School of Medicine, Kyoto, JPN)
,
BOKU N.
(St Marianna Univ. School of Medicine, Kawasaki)
,
HYODO I.
(Univ. Tsukuba, Tsukuba)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
27
号:
8
ページ:
1539-1546
発行年:
2016年08月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)